CN Patent

CN106074553B — 含有西格列汀和二甲双胍的药物组合物

Assigned to Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd · Expires 2019-02-22 · 7y expired

What this patent protects

本发明涉及药学领域，公开了一种含有磷酸西格列汀及盐酸二甲双胍的药物组合物。本发明公开的西格列汀二甲双胍药物组合物含有滑石粉与羟丙甲纤维素的隔离层。本发明所公开的西格列汀二甲双胍药物组合物体外溶出快，有关物质少，稳定性好，质量明显优于原研产品。

USPTO Abstract

本发明涉及药学领域，公开了一种含有磷酸西格列汀及盐酸二甲双胍的药物组合物。本发明公开的西格列汀二甲双胍药物组合物含有滑石粉与羟丙甲纤维素的隔离层。本发明所公开的西格列汀二甲双胍药物组合物体外溶出快，有关物质少，稳定性好，质量明显优于原研产品。

Drugs covered by this patent

Patent Metadata

Patent number
CN106074553B
Jurisdiction
CN
Classification
—
Expires
2019-02-22
Drug substance claim
No
Drug product claim
No
Assignee
Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.